The gastrointestinal tract and glucose tolerance
- PMID: 15192453
- DOI: 10.1097/01.mco.0000134375.01310.97
The gastrointestinal tract and glucose tolerance
Abstract
Purpose of review: The development of incretin hormones and incretin analogues for the therapy of diabetes highlights the importance of the gastrointestinal tract in the maintenance of glucose tolerance.
Recent findings: The review focuses on recent information on the role of incretins and their breakdown products on insulin secretion, gastric emptying, and satiety. The importance of gastric emptying and its absorptive potential as well as of dietary composition on gastric emptying and glucose tolerance is highlighted. The concept of a portal glucose sensor in humans has been the subject of some controversy but has been recently revisited.
Summary: The gastrointestinal tract plays an important part in glucose tolerance. In this review we have examined how factors altering gastric emptying, insulin secretion in response to meal ingestion, and gastric emptying contribute to the maintenance and deterioration of glucose tolerance.
Similar articles
-
The incretins: a link between nutrients and well-being.Br J Nutr. 2005 Apr;93 Suppl 1:S147-56. doi: 10.1079/bjn20041340. Br J Nutr. 2005. PMID: 15877888 Review.
-
Enteroinsular signaling: perspectives on the role of the gastrointestinal hormones glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in normal and abnormal glucose metabolism.Curr Opin Clin Nutr Metab Care. 2003 Jul;6(4):461-8. doi: 10.1097/01.mco.0000078991.96795.84. Curr Opin Clin Nutr Metab Care. 2003. PMID: 12806222 Review.
-
Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.J Clin Endocrinol Metab. 1996 Jan;81(1):327-32. doi: 10.1210/jcem.81.1.8550773. J Clin Endocrinol Metab. 1996. PMID: 8550773 Clinical Trial.
-
Gastric emptying and release of incretin hormones after glucose ingestion in humans.J Clin Invest. 1996 Jan 1;97(1):92-103. doi: 10.1172/JCI118411. J Clin Invest. 1996. PMID: 8550855 Free PMC article.
-
Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.Am J Physiol. 1997 Nov;273(5):E981-8. doi: 10.1152/ajpendo.1997.273.5.E981. Am J Physiol. 1997. PMID: 9374685 Clinical Trial.
Cited by
-
Pharmacogenetics for type 2 diabetes: practical considerations for study design.J Diabetes Sci Technol. 2009 Jul 1;3(4):705-9. doi: 10.1177/193229680900300415. J Diabetes Sci Technol. 2009. PMID: 20144317 Free PMC article.
-
Prandial insulin and the systemic appearance of meal-derived glucose in people with type 1 diabetes.Diabetes Care. 2008 Nov;31(11):2230-1. doi: 10.2337/dc08-1549. Diabetes Care. 2008. PMID: 18955720 Free PMC article. No abstract available.
-
Ethnic differences in beta cell adaptation to insulin resistance in obese children and adolescents.Diabetologia. 2006 Mar;49(3):571-9. doi: 10.1007/s00125-005-0109-z. Epub 2006 Feb 3. Diabetologia. 2006. PMID: 16456682
-
The sum of many parts: potential mechanisms for improvement in glucose homeostasis after bariatric surgery.Curr Diab Rep. 2014;14(5):481. doi: 10.1007/s11892-014-0481-5. Curr Diab Rep. 2014. PMID: 24705810 Free PMC article. Review.
-
Does caloric restriction alone explain the effects of Roux-en-Y gastric bypass on glucose metabolism? Not by a long limb.Diabetes. 2013 Sep;62(9):3017-8. doi: 10.2337/db13-0806. Diabetes. 2013. PMID: 23970521 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials